AI-generated summary
The authors report a multicenter case series from Brazil in which three protocols of intranasal photobiomodulation therapy were used for olfactory dysfunction related to COVID-19. They report olfaction recovery in all cases, though with varying degrees of improvement, and state that more research is needed to define effectiveness.
- Who or what was studied
- Patients with COVID-19-related olfactory dysfunction, treated across multiple centers in Brazil
- Limits stated in the abstract
- The abstract describes a case series and states that more research is needed to better define effectiveness.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Intranasal photobiomodulation, Photobiomodulation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.